作者:
Sharpe,K. [1]
;
Stewart,G.D. [2]
;
MacKay,A. [3]
;
VanNeste,C. [4]
;
Rofe,C. [5]
;
Berney,D. [6]
;
Kayani,I. [7]
;
Bex,A. [8]
;
Wan,E. [9]
;
O'Mahony,F.C. [10]
;
O'Donnell,M. ;
Chowdhury,S. ;
Doshi,R. ;
Ho-Yen,C. ;
Gerlinger,M. ;
Baker,D. ;
Smith,N. ;
Davies,B. ;
Sahdev,A. ;
Boleti,E. ;
DeMeyer,T. ;
VanCriekinge,W. ;
Beltran,L. ;
Lu,Y.-J. ;
Harrison,D.J. ;
Reynolds,A.R. ;
Powles,T.
作者单位:
Barts Cancer Institute, Queen Mary University of London, Translational Oncology, Experimental
[1]
Royal Free Hospital London, London, United Kingdom
[2]
University of Ghent, Ghent, Belgium
[3]
Edinburgh Urological Cancer Group, University of Edinburgh, Edinburgh, United Kingdom
[4]
Edinburgh Urological Cancer Group, University of Edinburgh, Edinburgh, United Kingdom, School of
[5]
Experimental Cancer Medicine Centre, University College, London, United Kingdom
[6]
Guys and St Thomas' Hospital, London, United Kingdom
[7]
National Cancer Institute, Amsterdam, Netherlands
[8]
Astra Zeneca, Manchester, United Kingdom
[9]
Institute of Cancer Research, London, United Kingdom
[10]
发布时间
2014-03-07